CVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.
Follow CVS
CVS Health Corporation (CVS) EPS (diluted)
CVS Health Corporation's EPS (diluted) for fiscal 2025 was $1.39, down 62.0% from $3.66 in fiscal 2024. Over the twelve months to 30 June 2026 it was $3.78. Over the past ten years it has ranged from −$0.57 (fiscal 2018) to $6.47 (fiscal 2023); the current reading is higher than 18% of that period. CVS Health Corporation ranks 5th of 12 Healthcare Plans companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $1.39 | (62.02%) |
| FY2024 | $3.66 | (43.43%) |
| FY2023 | $6.47 | 106.05% |
| FY2022 | $3.14 | (47.23%) |
| FY2021 | $5.95 | 8.97% |
| FY2020 | $5.46 | 7.48% |
| FY2019 | $5.08 | — |
| FY2018 | −$0.57 | — |
| FY2017 | $6.44 | 31.43% |
| FY2016 | $4.90 | 5.83% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $2.31 | 0.43% |
| Mar 2026 | $2.30 | 0.00% |
| Dec 2025 | $2.30 | — |
| Sep 2025 | −$3.13 | — |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CI Cigna Group compare | $24.17 |
| ELV Elevance Health, Inc. compare | $22.50 |
| UNH UnitedHealth Group Incorporated compare | $15.54 |
| HUM Humana Inc. compare | $10.57 |
| CVS CVS Health Corporation | $3.78 |
| OSCR Oscar Health, Inc. compare | $1.40 |
| CLOV Clover Health Investments, Corp. compare | −$0.05 |
| MOH Molina Healthcare, Inc compare | −$0.18 |
| CNC Centene Corporation compare | −$10.44 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CVS
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement